| 51 |
24086526 | Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis. | 2013 |
4 |
| 52 |
24331695 | [Anti-proliferation effect of sorafenib in combination with 5-FU for hepatocellular carcinoma in vitro: antagonistic performance and mechanism]. | 2013 Nov |
3 |
| 53 |
21979753 | Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1). | 2012 Feb 10 |
2 |
| 54 |
22180308 | Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3. | 2012 Feb |
2 |
| 55 |
22278289 | Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells. | 2012 Jan 26 |
1 |
| 56 |
22406995 | Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis. | 2012 May |
7 |
| 57 |
22414764 | Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells. | 2012 Jul |
1 |
| 58 |
22634008 | Combined anti-tumor effects of IFN-α and sorafenib on hepatocellular carcinoma in vitro and in vivo. | 2012 Jun 15 |
1 |
| 59 |
22787432 | The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. | 2012 Jun |
2 |
| 60 |
22871485 | Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity. | 2012 Sep |
2 |
| 61 |
22922424 | Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice. | 2012 Dec |
1 |
| 62 |
20881478 | Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation. | 2011 Jan |
8 |
| 63 |
21331764 | Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells. | 2011 Jun |
2 |
| 64 |
21531053 | Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf. | 2011 Jul |
3 |
| 65 |
21718664 | Targeting STAT3 in hepatocellular carcinoma: sorafenib again…. | 2011 Nov |
1 |
| 66 |
20197401 | Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. | 2010 Mar |
5 |
| 67 |
20371721 | Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3. | 2010 Apr |
10 |
| 68 |
20470863 | Sorafenib exerts anti-glioma activity in vitro and in vivo. | 2010 Jul 12 |
3 |
| 69 |
20490331 | Sorafenib downregulates ERK/Akt and STAT3 survival pathways and induces apoptosis in a human neuroblastoma cell line. | 2010 Apr 23 |
4 |
| 70 |
19821497 | Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2. | 2009 Dec |
6 |
| 71 |
19001435 | Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas. | 2008 Nov |
4 |